SCHEMBL30878331

SCHEMBL30878331

C#Cc1c(-c2ccccc2Cl)c(=O)n(C)c2nc(Nc3ccc(OCCN(C)C)cc3)ncc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 7/20 0.69
FGFR1 P11362 9/20 0.66
RIPK2 O43353 4/20 0.60
NOD2 Q9HC29 4/20 0.60
ACVR1 Q04771 3/20 0.60
SRC P12931 6/20 0.56
PDGFRB P09619 3/20 0.56
PDGFRA P16234 3/20 0.56
LCK P06239 2/20 0.56
KDR P35968 2/20 0.56
CHEK1 O14757 1/20 0.56
JAK2 O60674 1/20 0.56
PRKD3 O94806 1/20 0.56
MAP4K4 O95819 1/20 0.56
PAK4 O96013 1/20 0.56
ABL1 P00519 1/20 0.56
EGFR P00533 1/20 0.56
NTRK1 P04629 1/20 0.56
FYN P06241 1/20 0.56
CSF1R P07333 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879194 0.89 WEE1 (0.62) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878325 0.88 WEE1 (0.58) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878382 0.87 WEE1 (0.70) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878465 0.85 WEE1 (0.77) WEE1FGFR1SRCEGFRFGFR2
SCHEMBL30879020 0.83 WEE1 (0.56) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878417 0.83 WEE1 (0.54) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878454 0.81 FGFR1 (0.51) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878289 0.80 CDK4 (0.59) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878366 0.80 FGFR1 (0.66) WEE1FGFR1RIPK2NOD2ACVR1
SCHEMBL30878380 0.80 WEE1 (0.48) WEE1FGFR1SRCPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP claimed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO claimed
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed